Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel (BD OneFlow™ LST and OneFlow™ B-CLPD T1) on the BD FACSLyric™ Flow Cytometer Using Leftover, De-identified Specimens

NCT05032313 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.

NCT NCT05032313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05032313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel (BD OneFlow™ LST and OneFlow™ B-CLPD T1) on the BD FACSLyric™ Flow Cytometer Using Leftover, De-identified Specimens
Lead sponsor
Becton, Dickinson and Company
Phase
Observational
Overall status
Completed
Start date
April 26, 2021
Completion date
December 29, 2023
Enrollment
371 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphoproliferative diseases (clpd)